PhRMA
APRIL 7, 2023
PhRMA president and CEO Stephen J. Ubl spoke recently at The Hill’ s event, “ Pathways to Patient Affordability.” He spotlighted patients’ affordability challenges, the unintended consequences we’re already seeing from the government price setting provisions in the Inflation Reduction Act (IRA) and how policymakers can address harmful pharmacy benefit manager (PBM) practices.
Drug Topics
APRIL 7, 2023
Both acute and chronic infection can increase the risk of cognitive decline and dementia in older adults.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 7, 2023
In a case that could reshape pregnancy in America, a federal judge on Friday sided with anti-abortion groups seeking a nationwide ban on abortion pills, ruling that the Food and Drug Administration acted improperly in approving mifepristone in 2000. The ruling will go into effect in seven days if a stay is not granted by an appeals court or by the Supreme Court.
Drug Topics
APRIL 7, 2023
Dupilumab monotherapy plus concomitant topical corticosteroids can improve signs, symptoms, and patient health-related quality of life.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 7, 2023
I care deeply about privacy, and as a professional researcher, I take meticulous notes. During my recent maternity leave, I spent most of my hands-free time trying to figure out why my doctors were trying to give my medical data away to advertisers — even after I opted out.
Pharmacy Times
APRIL 7, 2023
Part 1 of this 2-part series examines USP and revisions for sterile and nonsterile compounding, veterinary compounding, FDA inspections of 503A pharmacies, and the interstate distribution of compounded prescriptions post Wellness Pharmacy v. FDA.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
APRIL 7, 2023
Eye drops come in many forms and for many indications, such as redness, itchiness, dryness, allergies, dilating drops, glaucoma drops, lubricants, numbing agents, antibiotics, and to lower pressure.
STAT
APRIL 7, 2023
Liver disease researchers, stumped by a complex disease, are looking for new investigative tools. Artificial intelligence might be one of them. At a small conference of the American Association for the Study of Liver Diseases in Los Angeles last month, experts gathered to compare notes on nonalcoholic steatohepatitis, a form of nonalcoholic fatty liver disease commonly known as NASH.
PharmExec
APRIL 7, 2023
Eli Lilly debuts its first Mounjaro TV commercial amid high demand for the diabetes injection, which also shows promise in weight loss applications and outperformed rivals Ozempic and Wegovy in clinical trials.
Pharmacy Times
APRIL 7, 2023
Discussions are led by a variety of experienced preceptors to provide insight, strategies, and resources for pharmacy residents.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
APRIL 7, 2023
Enanta Pharmaceuticals has secured the US Food and Drug Administration’s (FDA) fast track designation for EDP-323 to treat respiratory syncytial virus (RSV). In vitro data of EDP-323 showed a significant reduction in RSV replication with picomolar potency in primary human bronchial epithelial cells against RSV A and B. Consistent potency was also observed across a range of RSV clinical isolates in several cell types.
STAT
APRIL 7, 2023
When it comes to treating brain tumors, sometimes less is more in the operating room. If it’s a lymphoma, a doctor might want to just get enough tissue to confirm the diagnosis and get out. If it’s an astrocytoma, a surgeon will want to cut out every possible piece of the tumor. The same goes for oligodendroglioma, though for these tumors, getting out the last of a tumor may not be worth damaging the patient’s ability to walk or speak.
The Guardian - Pharmaceutical Industry
APRIL 7, 2023
Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives ‘A silver lining’: how Covid ushered in a vaccines golden era Millions of lives could be saved by a groundbreaking set of new vaccines for a range of conditions including cancer, experts have said. A leading pharmaceutical firm said it is confident that jabs for cancer, cardiovascular and autoimmune diseases, and other conditions will be ready by 2030.
STAT
APRIL 7, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
APRIL 7, 2023
DSN interviewed Omar Abdelsamad, executive director of patient recruitment, clinical trial services at CVS Health, about the company’s entry into a new therapeutic space—chronic kidney disease.
Fierce Healthcare
APRIL 7, 2023
Digital pathology experts say that human-centered augmented intelligence will remain the standard for pathology, radiology aburky Fri, 04/07/2023 - 16:13
Drug Store News
APRIL 7, 2023
In line with perceptions that consumers are less prone to buying bigger-ticket items in today’s economy, Costco’s March sales report showed resilience in food and downturns in nonfoods.
Pharmaceutical Technology
APRIL 7, 2023
The US Food and Drug Administration (FDA) has rescinded its approval for Swiss drug maker Covis Pharma’s (Covis) Makena drug and its generic versions , the only approved treatments aimed at reducing the risk of premature birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth. Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who hav
The Checkup by Singlecare
APRIL 7, 2023
Over-the-counter medications may provide an illusion of safety since they are available without a prescription. However, taking more than one OTC treatment at a time can have very serious consequences. Benadryl (diphenhydramine) and Zyrtec (cetririzine) are the brand names of common oral antihistamines. Here is what providers say about mixing these two over-the-counter allergy medications.
Pharmaceutical Technology
APRIL 7, 2023
The US Food and Drug Administration (FDA) has rescinded its approval for Swiss drug maker Covis Pharma’s (Covis) Makena drug and its generic versions , the only approved treatments aimed at reducing the risk of premature birth. The decision was made after studies did not prove the effectiveness of the drug in preventing preterm birth. Makena was approved by the FDA under the accelerated approval pathway in 2011 to reduce the risk of preterm birth in women with a singleton pregnancy who hav
Fierce Healthcare
APRIL 7, 2023
Sweeping new study analyzes maternal health outcomes with SDOH, finds Black mothers at much higher risk agliadkovskaya Fri, 04/07/2023 - 15:50
STAT
APRIL 7, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, once gain, rather modest. We plan to promenade with the official mascot and his stay-over playmate, catch up on our reading, and hold another listening party with Mrs. Pharmalot — the rotation will include this , this and this.
Drug Topics
APRIL 7, 2023
The drug, called Atovaquone, has been voluntarily recalled due to possible Bacillus cereus contamination.
PharmExec
APRIL 7, 2023
It’s time for pharma brands to recognize the potential of TikTok as a promotional platform and develop a strategy to not only stand out but make an impact.
Drug Store News
APRIL 7, 2023
The collection features an intensive repair solution that rebuilds broken bonds inside the hair while replenishing the outside barrier, the company said.
Fierce Healthcare
APRIL 7, 2023
Industry Voices—As healthcare's labor shortages worsen, masking remains critical pminemyer Fri, 04/07/2023 - 16:03
European Pharmaceutical Review
APRIL 7, 2023
A new, sustained-release chemotherapy delivery device inserted into the bladder, facilitated tumour response, a study has reported. The treatment was given to elderly patients with advanced bladder cancer who were medically unfit for standard treatment. The intravesical device, TAR-200, provides continuous, low-dose, local delivery of gemcitabine chemotherapy. “TAR-200 was generally safe, well tolerated, and had beneficial effects on bladder cancer outcomes,” commented lead author Dr
Fierce Healthcare
APRIL 7, 2023
Layoffs are ramping up among hospitals and health systems.
PharmExec
APRIL 7, 2023
Marketing leaders discuss the powerful role life sciences companies can play in the expanding digital landscape for healthcare communications—as “one of the helpful voices” in driving the customer and patient conversations that matter most.
Drug Topics
APRIL 7, 2023
Continuous glucose monitors are poised to change diabetes management for patients.
OctariusRx
APRIL 7, 2023
Happy Easter Weekend from all of us at OctariusRx! Wishing you a season filled with peace, joy, and beautiful weather. Happy Easter! The Consultant Pharmacists at OctariusRx provide guidance on safe medication management, survey readiness and cost savings to ambulatory healthcare facilities/surgery centers , senior care facilities and pharmacies.
Drug Store News
APRIL 7, 2023
Walmart plans to install new fast-charging stations at thousands of Walmart and Sam’s Club locations across the country.
Fierce Pharma
APRIL 7, 2023
Clovis sells off remaining assets—including cancer drug Rubraca—for $70M-plus kdunleavy Fri, 04/07/2023 - 10:33
Drug Store News
APRIL 7, 2023
The Kindness+ line includes two plant-based hand cleansers and moisturizers infused with hyaluronic acid and vitamin C.
Expert insights. Personalized for you.
196 
Let's personalize your content